Literature DB >> 31346878

A Combination of Muramylpeptides from Gram-Negative Bacteria Corrects Hematological and Immunological Disorders Induced by Cyclophosphamide.

M V Kiselevskii1, N Yu Anisimova2, S M Sitdikova2, F V Donenko2, S F Popilyuk3, V L L'vov4, O V Kalyuzhin5.   

Abstract

We have studied the effect of a combination of three natural muramylpeptides containing a meso-diaminopimelic acid residue (polyramyl) on the subpopulations of circulating T cells, spleen morphology, and leukocyte level in the blood of C57Bl/6 mice with cyclophosphamideinduced immunosuppression. Intraperitoneal injections of cyclophosphamide in a dose of 100 mg/kg on days 1, 3, 5, and 7 of the experiment reduced leukocyte count and the relative number of CD4+ T cells in the blood, and also depleted the cellular composition of splenic white pulp on day 10. Subcutaneous injections of polyramyl in a dose of 200 μg/mouse on days 8 and 9 practically completely restored blood leukocytes count and morphology of the splenic white pulp. Moreover, administration of polyramyl induced marked tendency to increase in the relative number of CD4+ T cells and CD4/CD8 ratio in mice with cyclophosphamideinduced immunosuppression.

Entities:  

Keywords:  cyclophosphamide; immunomodulation; immunosuppression; muramylpeptides; polymuramyl

Year:  2019        PMID: 31346878     DOI: 10.1007/s10517-019-04529-6

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  1 in total

1.  Combination of Muramylpeptides from Gram-Negative Bacteria Corrects Cyclophosphamide-Induced Disorders of Hematopoiesis and Spleen Cell Composition in Mice with B16 Melanoma.

Authors:  M V Kiselevskii; N Yu Anisimova; S M Sitdikova; F V Donenko; V L L'vov; O V Kalyuzhin; A Yu Nurtazina; A V Karaulov
Journal:  Bull Exp Biol Med       Date:  2021-04-24       Impact factor: 0.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.